Nocturia Global Market Report 2025

Nocturia Global Market Report 2025 - By Drug (Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Other Drugs), By Indication (Mixed Nocturia, Low Nocturnal Bladder Capacity, Nocturnal Polyuria, Global Polyuria), By Causes (Urological Infection, Tumor Of The bladder, Diuretic Medications, Regular Alcohol Or coffee, Liver infection, Diabetes, Pregnancy, Other Causes), By End User (Hospitals, Home Care, Clinics) - Market Size, Trends, And Global Forecast 2025-2034

Name: Nocturia Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Nocturia Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

What Is Covered Under Nocturia Market?

Nocturia is a medical condition characterized by the need to wake up at night one or more times to urinate. It is considered a lower urinary tract symptom (LUTS) and can result from various underlying causes, including excessive fluid intake before bedtime, overactive bladder, urinary tract infections, diabetes, or prostate enlargement in men. Nocturia can significantly impact sleep quality and overall health, leading to fatigue and decreased daytime productivity.

The main drugs of nocturia are anticholinergic drugs, desmopressin, antibiotics, antispasmodics, and other medications. Anticholinergic drugs block acetylcholine to reduce involuntary bladder contractions, helping manage overactive bladder and nocturia. The main clinical indications for these drugs are mixed nocturia, low nocturnal bladder capacity, nocturnal polyuria, and global polyuria. Nocturia can be caused by urological infections, bladder tumors, diuretic medications, regular alcohol or coffee consumption, liver infections, diabetes, pregnancy, and other factors. These drugs are used by various end users, including hospitals, home care settings, and clinics.

What Is The Nocturia Market Size 2025 And Growth Rate?

The nocturia market size has grown strongly in recent years. It will grow from $2.87 billion in 2024 to $3.11 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growing prevalence of cardiovascular diseases, increase in incidence of insomnia, rise in aging population, rising awareness of nocturia and related conditions, and increase in comorbidities.

What Is The Nocturia Market Growth Forecast?

The nocturia market size is expected to see strong growth in the next few years. It will grow to $4.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing prevalence of bladder obstruction disorders and urinary tract inflammation, rising incidence of excess urine production at night (nocturia) due to various risk factors, high intake of fluids contributing to nocturia, increasing awareness of nocturia’s connection to sleep disorders and kidney health, and aging population growth. Major trends in the forecast period include advancements in diagnostics, development of new drugs, increased research and investment in nocturia treatments, surgical and non-surgical treatment advancements, and adoption of personalized medicine.

Nocturia Market Size and growth rate 2025 to 2029: Graph

How Is The Nocturia Market Segmented?

The nocturia market covered in this report is segmented –

1) By Drug: Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Other Drugs

2) By Indication: Mixed Nocturia, Low Nocturnal Bladder Capacity, Nocturnal Polyuria, Global Polyuria

3) By Causes: Urological Infection, Tumor Of The bladder, Diuretic Medications, Regular Alcohol Or coffee, Liver infection, Diabetes, Pregnancy, Other Causes

4) By End User: Hospitals, Home Care, Clinics

Subsegments:

1) By Anticholinergic Drugs: Oxybutynin, Tolterodine, Solifenacin, Darifenacin, Fesoterodine

2) By Desmopressin: Intranasal Desmopressin, Oral Desmopressin

3) By Antibiotics: Nitrofurantoin, Trimethoprim, Fosfomycin, Other Antibiotics

4) By Antispasmodic: Hyoscine Butylbromide, Flavoxate, Other Antispasmodics

5) By Other Drugs: Alpha-blockers, Beta-3 Agonists, Diuretics, Other Pharmacological Treatments

Book your 30 minutes free consultation with our research experts

What Is Driving The Nocturia Market? Impact Of Cardiovascular Disease Prevalence On The Growth Of The Market

The growing prevalence of cardiovascular diseases is expected to propel the growth of the nocturia market going forward. Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions such as heart disease, stroke, and hypertension. The prevalence of cardiovascular diseases can be attributed to factors such as aging populations, sedentary lifestyles, unhealthy diets, smoking, excessive alcohol consumption, obesity, high blood pressure, high cholesterol, diabetes, and genetic predisposition. Patients with cardiovascular diseases often experience nocturia as a symptom, leading to higher demand for diagnosis and treatment solutions. As cardiovascular conditions continue to rise globally due to aging populations and unhealthy lifestyles, the need for effective nocturia management will grow. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, heart disease in the US was responsible for 702,880 fatalities in 2022, representing 20% of all deaths in the United States. Annually, approximately 805,000 individuals experience a heart attack, with 605,000 being first-time cases and 200,000 occurring in those with a prior history. Therefore, the growing prevalence of cardiovascular diseases is driving the growth of the nocturia market.

Who Are The Major Players In The Global Nocturia Market?

Major companies operating in the nocturia market are Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc

What Are The Key Trends Of The Global Nocturia Market? Impact Of Orally Disintegrating Tablets On Treatment Compliance And Outcomes

Major companies operating in the nocturia market are focusing on developing innovative products, such as orally disintegrating tablets, to enhance patient convenience and compliance. Orally disintegrating tablets (ODTs) are solid dosage forms that dissolve quickly in the mouth without needing water, making them ideal for patients with difficulty swallowing. For instance, in July 2024, Adalvo Limited, a Malta-based pharmaceutical company, launched Desmopressin ODT in Europe to treat conditions that cause the body to lose too much fluid, such as central cranial diabetes insipidus. This synthetic form of vasopressin tablet treats diabetes insipidus, excessive thirst and urination, and bedwetting by mimicking the natural hormone and limiting the amount of water eliminated in urine. It is also used to manage bleeding in mild to moderate hemophilia A and von Willebrand disease by promoting the release of blood clotting factors.

What Are Latest Mergers And Acquisitions In The Nocturia Market? Acerus Pharmaceuticals Acquires Serenity Pharmaceuticals To Expand Urology And Men’s Health Portfolio

In March 2022, Acerus Pharmaceuticals Corporation, a Canada-based biopharmaceutical company, acquired Serenity Pharmaceuticals LLC for an undisclosed amount. With this acquisition, Acerus Pharmaceuticals aims to gain global rights to Noctiva and expand its portfolio in urology and men’s health, positioning the company for faster growth and improved long-term performance. Serenity Pharmaceuticals LLC is a US-based pharmaceutical company focused on developing therapies for voiding disorders and conditions related to urinary health, such as nocturia.

What Is The Regional Outlook For The Global Nocturia Market?

North America was the largest region in the nocturia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nocturia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nocturia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nocturia Market?

The nocturia market consists of revenues earned by entities by providing services such as diagnostic services, pharmacological treatment services, behavioral therapy and lifestyle modification services and telemedicine and remote consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The nocturia market also includes sales of bladder control devices, alpha-blockers, diuretics, and tricyclic antidepressants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Nocturia Industry?

The nocturia market research report is one of a series of new reports from The Business Research Company that provides nocturia market statistics, including the nocturia industry global market size, regional shares, competitors with the nocturia market share, detailed nocturia market segments, market trends, and opportunities, and any further data you may need to thrive in the nocturia industry. This nocturia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Nocturia Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.11 billion
Revenue Forecast In 2034	$4.23 billion
Growth Rate	CAGR of 8.0% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The nocturia market covered in this report is segmented – 1) By Drug: Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Other Drugs 2) By Indication: Mixed Nocturia, Low Nocturnal Bladder Capacity, Nocturnal Polyuria, Global Polyuria 3) By Causes: Urological Infection, Tumor Of The bladder, Diuretic Medications, Regular Alcohol Or coffee, Liver infection, Diabetes, Pregnancy, Other Causes 4) By End User: Hospitals, Home Care, Clinics Subsegments: 1) By Anticholinergic Drugs: Oxybutynin, Tolterodine, Solifenacin, Darifenacin, Fesoterodine 2) By Desmopressin: Intranasal Desmopressin, Oral Desmopressin 3) By Antibiotics: Nitrofurantoin, Trimethoprim, Fosfomycin, Other Antibiotics 4) By Antispasmodic: Hyoscine Butylbromide, Flavoxate, Other Antispasmodics 5) By Other Drugs: Alpha-blockers, Beta-3 Agonists, Diuretics, Other Pharmacological Treatments
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Nocturia Market Characteristics

3. Nocturia Market Trends And Strategies

4. Nocturia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Nocturia Growth Analysis And Strategic Analysis Framework

5.1. Global Nocturia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Nocturia Market Growth Rate Analysis

5.4. Global Nocturia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Nocturia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Nocturia Total Addressable Market (TAM)

6. Nocturia Market Segmentation

6.1. Global Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Anticholinergic Drugs

Desmopressin

Antibiotics

Antispasmodic

Other Drugs

6.2. Global Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mixed Nocturia

Low Nocturnal Bladder Capacity

Nocturnal Polyuria

Global Polyuria

6.3. Global Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Urological Infection

Tumor Of The bladder

Diuretic Medications

Regular Alcohol Or coffee

Liver infection

Diabetes

Pregnancy

Other Causes

6.4. Global Nocturia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Home Care

Clinics

6.5. Global Nocturia Market, Sub-Segmentation Of Anticholinergic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oxybutynin

Tolterodine

Solifenacin

Darifenacin

Fesoterodine

6.6. Global Nocturia Market, Sub-Segmentation Of Desmopressin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intranasal Desmopressin

Oral Desmopressin

6.7. Global Nocturia Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nitrofurantoin

Trimethoprim

Fosfomycin

Other Antibiotics

6.8. Global Nocturia Market, Sub-Segmentation Of Antispasmodic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hyoscine Butylbromide

Flavoxate

Other Antispasmodics

6.9. Global Nocturia Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alpha-blockers

Beta-3 Agonists

Diuretics

Other Pharmacological Treatments

7. Nocturia Market Regional And Country Analysis

7.1. Global Nocturia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Nocturia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nocturia Market

8.1. Asia-Pacific Nocturia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nocturia Market

9.1. China Nocturia Market Overview

9.2. China Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nocturia Market

10.1. India Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nocturia Market

11.1. Japan Nocturia Market Overview

11.2. Japan Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nocturia Market

12.1. Australia Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nocturia Market

13.1. Indonesia Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nocturia Market

14.1. South Korea Nocturia Market Overview

14.2. South Korea Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nocturia Market

15.1. Western Europe Nocturia Market Overview

15.2. Western Europe Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nocturia Market

16.1. UK Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nocturia Market

17.1. Germany Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nocturia Market

18.1. France Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nocturia Market

19.1. Italy Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nocturia Market

20.1. Spain Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nocturia Market

21.1. Eastern Europe Nocturia Market Overview

21.2. Eastern Europe Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nocturia Market

22.1. Russia Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nocturia Market

23.1. North America Nocturia Market Overview

23.2. North America Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nocturia Market

24.1. USA Nocturia Market Overview

24.2. USA Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nocturia Market

25.1. Canada Nocturia Market Overview

25.2. Canada Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nocturia Market

26.1. South America Nocturia Market Overview

26.2. South America Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nocturia Market

27.1. Brazil Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nocturia Market

28.1. Middle East Nocturia Market Overview

28.2. Middle East Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nocturia Market

29.1. Africa Nocturia Market Overview

29.2. Africa Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nocturia Market Competitive Landscape And Company Profiles

30.1. Nocturia Market Competitive Landscape

30.2. Nocturia Market Company Profiles

30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Nocturia Market Other Major And Innovative Companies

31.1. Viatris Inc

31.2. Boehringer Ingelheim International GmbH

31.3. Otsuka Pharmaceutical Co. Ltd

31.4. Astellas Pharma Inc

31.5. Eisai Co. Ltd.

31.6. Sumitomo Dainippon Pharma Co. Ltd

31.7. Ferring Pharmaceuticals A/S

31.8. Avadel Pharmaceuticals plc

31.9. UroGen Pharma Ltd

31.10. Sanwa Kagaku Co. Ltd.

31.11. Urovant Sciences Inc

31.12. Serenity Pharmaceuticals LLC

31.13. Vantia Therapeutics Inc

31.14. AA Pharma Inc

31.15. Wellesley Pharmaceuticals Inc

32. Global Nocturia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nocturia Market

34. Recent Developments In The Nocturia Market

35. Nocturia Market High Potential Countries, Segments and Strategies

35.1 Nocturia Market In 2029 - Countries Offering Most New Opportunities

35.2 Nocturia Market In 2029 - Segments Offering Most New Opportunities

35.3 Nocturia Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Nocturia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Nocturia Market, Sub-Segmentation Of Anticholinergic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Nocturia Market, Sub-Segmentation Of Desmopressin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Nocturia Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Nocturia Market, Sub-Segmentation Of Antispasmodic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Nocturia Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Nocturia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Nocturia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Pfizer Inc Financial Performance

Table 81: Merck & Co. Inc Financial Performance

Table 82: AbbVie Inc Financial Performance

Table 83: Sanofi S.A Financial Performance

Table 84: GlaxoSmithKline plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Nocturia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Nocturia Market, Sub-Segmentation Of Anticholinergic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Nocturia Market, Sub-Segmentation Of Desmopressin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Nocturia Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Nocturia Market, Sub-Segmentation Of Antispasmodic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Nocturia Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Nocturia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Nocturia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Pfizer Inc Financial Performance

Figure 81: Merck & Co. Inc Financial Performance

Figure 82: AbbVie Inc Financial Performance

Figure 83: Sanofi S.A Financial Performance

Figure 84: GlaxoSmithKline plc Financial Performance

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Global Central Lab Market 2022 – Market Opportunities And Strategies

What Is The Biohacking Market Overview In 2022?

How Will The Healthcare Claims Management Solutions Market Grow In 2022?

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Sleep Apnea Devices Global Market Report 2025 – By Product Type (Airway Clearance System, Adaptive Servo-Ventilation (ASV), Positive Airway Pressure (PAP) Devices, Oral Appliances, Oxygen Devices, Sleep Screening Devices, Actigraphy Systems, Polysomnography (PSG) Device, Respiratory Polygraph), By Patient Type (Pediatric, Adult, Geriatric), By Disease (Obstructive Sleep Apnea Syndrome, Central Sleep Apnea Syndrome, Complex Sleep Apnea Syndrome), By End User (Hospital And Clinics, Diagnostic Centers, Ambulatory Care Centers, Specialty Care Center, Home Healthcare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Sleep Tech Devices Global Market Report 2025 – By Product Type (Wearable, Monitoring Devices, Smart Gadgets, Digital Tools, Other Types), By Age (Below 45 Years, 45–64 Years, Above 65 Years), By Distribution Channel (Sleep Centers And Fitness Centers, Hypermarkets And Supermarkets, E-Commerce, Pharmacy And Retail Stores, Other Channels), By Application (Insomnia, Obstructive Sleep Apnea, Narcolepsy, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Sleep Testing Services Global Market Report 2025 – By Diagnostic Type (Home Sleep Testing, In-Lab Sleep Testing), By Application (Obstructive Sleep Apnea, Insomnia, Rapid Eye Movement (REM) Sleep Disorder, Restless Legs Syndrome, Narcolepsy, Circadian Rhythm Sleeping Disorders), By End-User (Sleep Centers, Hospitals, Home Care Settings) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Pacemakers Global Market Report 2025 – By Type (Implantable, External), By Technology (Biventricular, Single Chambered, Dual Chambered), By Application (Arrhythmias, Heart Blockage, Atrial Fibrillation, Long QT Syndrome, Congestive Cardiac Failure, Other Applications), By End User (Clinics And Hospitals, Ambulatory Surgical Centers, Cardiac Care Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Valve Global Market Report 2025 – By Type (Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves, Other Types), By Position (Aortic Valve, Mitral Valve, Other Positions), By Treatment (Cardiac Valve Repair, Cardiac Valve Replacement), By End-Users (Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Arrhythmia Monitoring Devices Global Market Report 2025 – By Type (Standards in Ambulatory Cardiac Monitoring, Patient- and Event-activated Intermittent Recorders, External Loop Recorder Pre-symptom Memory Loop Cardiac Event Recorder, Post-symptom Event Recorder, Continuous Real-time Attended Remote Cardiac Monitors, Mobile Cardiac Outpatient Telemetry System, Vital Signs Transmitter (Bio Watch Medical)), By Device (Holter Monitor, Event Recorder, Mobile Cardiac Telemetry, Implantable Cardiac Monitor, Electrocardiogram (ECG) Monitor, Other Devices), By Application (Tachycardia, Bradycardia, Premature Contraction, Other Applications), By End-use (Hospitals and Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, Other End-uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Biomarkers Testing Global Market Report 2025 – By Biomarkers Type (Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified albumin (IMA), Other Biomarkers Types), By Application (Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications), By End-User (Hospitals, Specialty Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cardiac Marker Global Market Report 2025 – By Biomarker (Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers), By Product (Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA), By Indication (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications), By End User (Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Nocturia market?

How will the Nocturia market drivers and restraints affect the market dynamics? What forces will shape the Nocturia industry going forward?

The Nocturia market major growth driver - Impact Of Cardiovascular Disease Prevalence On The Growth Of The Market. For further insights on the Nocturia market, request a sample here

What is the forecast market size or the forecast market value of the Nocturia market?

The Nocturia market size has grown strongly in recent years. The nocturia market size has grown strongly in recent years. It will grow from $2.87 billion in 2024 to $3.11 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to growing prevalence of cardiovascular diseases, increase in incidence of insomnia, rise in aging population, rising awareness of nocturia and related conditions, and increase in comorbidities. The nocturia market size is expected to see strong growth in the next few years. It will grow to $4.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing prevalence of bladder obstruction disorders and urinary tract inflammation, rising incidence of excess urine production at night (nocturia) due to various risk factors, high intake of fluids contributing to nocturia, increasing awareness of nocturia’s connection to sleep disorders and kidney health, and aging population growth. Major trends in the forecast period include advancements in diagnostics, development of new drugs, increased research and investment in nocturia treatments, surgical and non-surgical treatment advancements, and adoption of personalized medicine. For further insights on the Nocturia market, request a sample here

How is the Nocturia market segmented?

The nocturia market covered in this report is segmented –
1) By Drug: Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Other Drugs
2) By Indication: Mixed Nocturia, Low Nocturnal Bladder Capacity, Nocturnal Polyuria, Global Polyuria
3) By Causes: Urological Infection, Tumor Of The bladder, Diuretic Medications, Regular Alcohol Or coffee, Liver infection, Diabetes, Pregnancy, Other Causes
4) By End User: Hospitals, Home Care, Clinics

Subsegments:
1) By Anticholinergic Drugs: Oxybutynin, Tolterodine, Solifenacin, Darifenacin, Fesoterodine
2) By Desmopressin: Intranasal Desmopressin, Oral Desmopressin
3) By Antibiotics: Nitrofurantoin, Trimethoprim, Fosfomycin, Other Antibiotics
4) By Antispasmodic: Hyoscine Butylbromide, Flavoxate, Other Antispasmodics
5) By Other Drugs: Alpha-blockers, Beta-3 Agonists, Diuretics, Other Pharmacological Treatments For further insights on the Nocturia market, request a sample here

Which region has the largest share of the Nocturia market? What are the other regions covered in the report?

Who are the major players in the Nocturia market?

What are the key trends in the Nocturia market?

Major trends in the Nocturia market include Impact Of Orally Disintegrating Tablets On Treatment Compliance And Outcomes. For further insights on the Nocturia market, request a sample here.

What are the major opportunities in the Nocturia market? What are the strategies for the Nocturia market?

For detailed insights on the major opportunities and strategies in the Nocturia market, request a sample here.

How does the Nocturia market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Nocturia market growth and SWOT analysis of the Nocturia industry, request a sample here.

For detailed insights on Nocturia's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Nocturia industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Nocturia industry,

What are the key dynamics influencing the Nocturia market growth? SWOT analysis of the Nocturia market. request a sample here.